An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics
Simon de Denus(Montreal Heart Institute), Barbara Vadnais(Hôpital Maisonneuve-Rosemont), Thierry Hurlimann(Université de Montréal), Laura Robb(Montreal Heart Institute), Jacques Turgeon(Académie Nationale de Médecine), Nancy L. Sheehan(McGill University Health Centre), Jean‐Philippe Lambert, Annie Lavoie(Centre Hospitalier Universitaire Sainte-Justine), Nathalie Letarte(Centre Hospitalier de l’Université de Montréal)
Cited by 80
Related Papers
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
|OncoImmunology|2019|207
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186